Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metformin in CFRD on CFTR Modulator Therapy
NCT04530383Phase 2Recruiting
- Sponsor
- University of Kansas Medical Center
- Start
- Feb 2022
- Primary completion
- Dec 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of metformin in cystic fibrosis-related diabetes (CFRD), cystic fibrosis (CF), sponsored by University of Kansas Medical Center. Started Feb 2022; status: recruiting.
02
Drugs
metformin
03
Conditions
cystic fibrosis-related diabetes (CFRD)cystic fibrosis (CF)
Beyond the preview
Go deeper on NCT04530383.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04530383.